Bioequivalence, pharmacokinetics, atorvastatin
Showing 1 - 25 of >10,000
Bioequivalence Trial in Yaroslavl (Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg)
Recruiting
- Bioequivalence
- Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg
-
Yaroslavl, Russian FederationState Budgetary Healthcare Institution of the Yaroslavl Region "
Nov 30, 2022
Healthy Volunteers Trial in Toronto (Obicetrapib, Atorvastatin Calcium, Rosuvastatin Calcium)
Not yet recruiting
- Healthy Volunteers
- Obicetrapib
- +2 more
-
Toronto, Ontario, CanadaMark M Feldman
Oct 10, 2023
Pharmacokinetics, Bioequivalence Trial in Dallas (Sumatriptan (via Intraject System))
Completed
- Pharmacokinetics
- Bioequivalence
- Sumatriptan (via Intraject System)
-
Dallas, TexasCovance, Inc
Nov 8, 2022
Healthy Volunteers Trial in Seoul (DWJ1558, DWC202310 and DWC202311)
Active, not recruiting
- Healthy Volunteers
- DWJ1558
- DWC202310 and DWC202311
-
Seoul, Korea, Republic ofH Plus YANGJI Hospital
Aug 28, 2023
Chronic Kidney Disease Trial in Beijing (Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin)
Recruiting
- Chronic Kidney Disease
- Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
-
Beijing, ChinaPeking University Third Hospital
Feb 27, 2023
Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)
Recruiting
- Diabetes
- INS062 injection
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Feb 8, 2023
Hypercholesterolemia Trial in Miami (Atorvastatin)
Completed
- Hypercholesterolemia
-
Miami, FloridaPfizer Investigational Site
Feb 17, 2021
Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)
Completed
- Healthy Adult Participants
- Treatment A
- +2 more
-
Baltimore, MarylandBaltimore Parexel EPCU
Jan 19, 2023
Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)
Not yet recruiting
- Viral Infection COVID-19
-
Saint Petersburg,, Russian FederationLimited Liability Company "Research Center Eco-Safety"
Oct 23, 2023
Healthy Adults Trial in Anaheim (PF-06882961, Atorvastatin, Midazolam)
Completed
- Healthy Adults
- PF-06882961
- +3 more
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jul 21, 2022
Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)
Not yet recruiting
- Leukemia
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 28, 2023
Hypercholesterolemia Trial in Miami (Atorvastatin)
Completed
- Hypercholesterolemia
-
Miami, FloridaPfizer Investigational Site
Feb 17, 2021
Hepatocellular Carcinoma Trial in Osong (BR2008-1 (R), BR2008 (T))
Completed
- Hepatocellular Carcinoma
- BR2008-1 (R)
- BR2008 (T)
-
Osong, Korea, Republic ofBestian Hospital
Apr 19, 2022
Pregnancy Related, Nausea Trial in Moscow (Doxylamine + Pyridoxine)
Recruiting
- Pregnancy Related
- Nausea
- Doxylamine + Pyridoxine
-
Moscow, Russian FederationLlc "Certa Clinic"
Aug 9, 2022
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)
Active, not recruiting
- Bioequivalence
- Rivastigmine twice-weekly 9,5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023